Literature DB >> 28466032

Identification of new potent inhibitors of dengue virus NS3 protease from traditional Chinese medicine database.

Vivek Dhar Dwivedi1,2, Indra Prasad Tripathi1, Shiv Bharadwaj3, Aman Chandra Kaushik4, Sarad Kumar Mishra2.   

Abstract

Dengue virus (DENV) has emerged as an increasing fitness problem in the world for which no specialized drug is available. The non-structural protein NS3 protease of DENV has already been recognized as a potential therapeutic target for the discovery and development of novel antiviral agents against DENV infections. In this study, we employed the virtual screening technique to explore the potent inhibitors of DENV NS2B/NS3pro from Traditional Chinese Medicine (TCM) database. Total 200 inhibitors from TCM against DENV NS3pro were screened and only five TCM compounds like eriodictyol 7-O-glucuronide, luteolin 8-C-beta-glucopyranoside, (-)-epicatechin-3-O-gallate, 6-O-trans-p-coumaroylgeniposide and luteolin-7-O-glucoside were selected for further analysis which showed binding energies, -7.000, -7.380, -7.380, -7.440 and -7.440 kcal/mol, respectively. The findings of this study suggest that these five TCM compounds can be considered as potent inhibitors for DENV NS2B/NS3pro for the development of anti-dengue drugs.

Entities:  

Keywords:  Dengue; Drug discovery; Inhibitors; NS2B/NS3; TCM

Year:  2016        PMID: 28466032      PMCID: PMC5394702          DOI: 10.1007/s13337-016-0328-6

Source DB:  PubMed          Journal:  Virusdisease        ISSN: 2347-3584


  39 in total

1.  Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication.

Authors:  A E Matusan; M J Pryor; A D Davidson; P J Wright
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.

Authors:  Vivek Dhar Dwivedi; Indra Prasad Tripathi; Sarad Kumar Mishra
Journal:  J Vector Borne Dis       Date:  2016 Apr-Jun       Impact factor: 1.688

3.  iScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan.

Authors:  Tsung-Ying Tsai; Kai-Wei Chang; Calvin Yu-Chian Chen
Journal:  J Comput Aided Mol Des       Date:  2011-06-07       Impact factor: 3.686

4.  Mutagenesis of the NS3 protease of dengue virus type 2.

Authors:  R P Valle; B Falgout
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain.

Authors:  C F Arias; F Preugschat; J H Strauss
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

Review 6.  Dengue hemorrhagic fever and shock syndromes.

Authors:  Suchitra Ranjit; Niranjan Kissoon
Journal:  Pediatr Crit Care Med       Date:  2011-01       Impact factor: 3.624

7.  Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing.

Authors:  Rohan Patil; Suranjana Das; Ashley Stanley; Lumbani Yadav; Akulapalli Sudhakar; Ashok K Varma
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

8.  PRODUCTION OF IMMUNITY TO DENGUE WITH VIRUS MODIFIED BY PROPAGATION IN MICE.

Authors:  A B Sabin; R W Schlesinger
Journal:  Science       Date:  1945-06-22       Impact factor: 47.728

9.  NS3 protease from flavivirus as a target for designing antiviral inhibitors against dengue virus.

Authors:  Satheesh Natarajan
Journal:  Genet Mol Biol       Date:  2010-06-01       Impact factor: 1.771

10.  PLIC: protein-ligand interaction clusters.

Authors:  Praveen Anand; Deepesh Nagarajan; Sumanta Mukherjee; Nagasuma Chandra
Journal:  Database (Oxford)       Date:  2014-04-23       Impact factor: 3.451

View more
  4 in total

Review 1.  Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro).

Authors:  Soumya Gulab Katre; Alpana Jagdish Asnani; Kumar Pratyush; Nilima Gangadhar Sakharkar; Ashwini Gajanan Bhope; Kanchan Tekram Sawarkar; Vaibhav Santosh Nimbekar
Journal:  Futur J Pharm Sci       Date:  2022-06-21

2.  Taraxacum officinale and Urtica dioica extracts inhibit dengue virus serotype 2 replication in vitro.

Authors:  María R Flores-Ocelotl; Nora H Rosas-Murrieta; Diego A Moreno; Verónica Vallejo-Ruiz; Julio Reyes-Leyva; Fabiola Domínguez; Gerardo Santos-López
Journal:  BMC Complement Altern Med       Date:  2018-03-16       Impact factor: 3.659

3.  Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease.

Authors:  Shiv Bharadwaj; Kyung Eun Lee; Vivek Dhar Dwivedi; Umesh Yadava; Aleksha Panwar; Stuart J Lucas; Amit Pandey; Sang Gu Kang
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

4.  Computational and In Vitro Investigation of (-)-Epicatechin and Proanthocyanidin B2 as Inhibitors of Human Matrix Metalloproteinase 1.

Authors:  Kyung Eun Lee; Shiv Bharadwaj; Umesh Yadava; Sang Gu Kang
Journal:  Biomolecules       Date:  2020-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.